ada standards of care 2025 glp-1 receptor agonists recommendations in Diabetes Guidelines Must read for all doctors ▪️ Cardiovascular risk: Use RA or SGLT2 inhibitors for glycemic control & cardiovascular risk reduction. ▪️ Heart failure: 10 Highlights of the ADA

The Moro orange, known for its deep pigmentation due to a high concentration of anthocyanins, is thought to have originated in Sicily in the early 1800s

7.40.8 Eq/min/gkw)

Indication expansion, such as approvals for additional metabolic and cardiovascular conditions, is broadening patient access and driving adoption

Most Medicaid programs cover GLP-1s for Type 2 diabetes, but weight loss coverage varies

New users of GLP-1RAs were matched based on age, demographics, comorbidities and medication use by using 1:1 propensity matching with other glucose-lowering drugs

Since type 2 diabetes mellitus (T2DM) is a risk factor for Alzheimers disease (AD) and both have the same pathogenesis (e.g., insulin resistance), drugs used to treat T2DM have been gradually found to reduce the progression of AD in AD models